Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion.

Cardiovascular research - 1 Apr 2004

Jiang Zhi-Sheng, Srisakuldee Wattamon, Soulet Fabienne, Bouche Gerard, Kardami Elissavet

Abstract excerpt

OBJECTIVE: Fibroblast growth factor-2 (FGF-2), given during ischemia or during reperfusion of the ischemic heart is cardioprotective, but its mitogenic activity may limit possible clinical applications. We have tested the cardioprotective potential of a non-mitogenic FGF-2 mutant (S117A) that no...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Circulation
Share to Cytochromes c
Share to Echocardiography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibroblast Growth Factor 2

Share to Myocardial Ischemia

Share to Myocardial Reperfusion Injury

Share to Myocardium

Share to Protein Kinase C

Source

Identifiers

PMID: 15023562
DOI: 10.1016/j.cardiores.2004.01.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15023562-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion.PMID 15023562Read ↗

Myocardial IGF2R is a critical mediator of inflammation and fibrosis after ischemia-reperfusion injurySemantic proximity Read ↗

A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.Semantic proximity Read ↗

Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches.Semantic proximity Read ↗

Insulin growth-factor 1Ea gene transfer therapy after myocardial infarctionSemantic proximity Read ↗

Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration.Semantic proximity Read ↗

Reproducing extracellular matrix adverse remodelling of non-ST myocardial infarction in a large animal modelSemantic proximity Read ↗

Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation.Semantic proximity Read ↗

Stem cell-related cardiac gene expression early after murine myocardial infarctionSemantic proximity Read ↗

Animal models of myocardial infarction: Mainstay in clinical translation.Semantic proximity Read ↗

Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction.Semantic proximity Read ↗

Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.Semantic proximity Read ↗

p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.